Successful sequential treatment with itraconazole and ALA-PDT for chromoblastomycosis because ofAlternaria alternata
Authors:
- 12 July 2014
- journal article
- case report
- Published by Wiley in Dermatologic Therapy
- Vol. 27 (6) , 357-360
Abstract
Alternaria alternata is a rare etiology of phaeohyphomycosis in immunocompromised patients, which has never been reported to cause chromoblastomycosis. As far as we know, this is the first chromoblastomycosis case successfully treated with a short course of systemic antifungals and subsequent 5-aminolevulinic acid-photodynamic therapy.Keywords
Funding Information
- Beaureau of Science and Technology of Hangzhou (20100733Q09)
This publication has 9 references indexed in Scilit:
- Challenges in the Therapy of ChromoblastomycosisMycopathologia, 2013
- A refractory case of chromoblastomycosis due to Fonsecaea monophora with improvement by photodynamic therapyMedical Mycology, 2012
- In vitro photodynamic therapy against Foncecaea pedrosoi and Cladophialophora carrioniiMycoses, 2012
- Photodynamic Antifungal Therapy Against ChromoblastomycosisMycopathologia, 2011
- Chromoblastomycosis: clinical presentation and managementClinical and Experimental Dermatology, 2009
- Chromoblastomycosis: an overview of clinical manifestations, diagnosis and treatmentMedical Mycology, 2009
- ChromoblastomycosisClinics in Dermatology, 2007
- Cutaneous alternariosis in transplant recipients: Clinicopathologic review of 9 casesJournal of the American Academy of Dermatology, 2005
- A comprehensive overview of photodynamic therapy in the treatment of superficial fungal infections of the skinJournal of Photochemistry and Photobiology B: Biology, 2005